| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.07 |